These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2818456)

  • 1. Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Rattert B; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():225-33. PubMed ID: 2818456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Hasenfuss G; Holubarsch C; Heiss HW; Just H
    Am Heart J; 1989 Sep; 118(3):512-9. PubMed ID: 2773772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H
    Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Hofmann T; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S69-74. PubMed ID: 2480489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
    Holubarsch C; Hasenfuss G; Heiss WH; Just H
    Am J Cardiol; 1988 Sep; 62(8):104E-107E. PubMed ID: 2970783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1984 Jul; 52(1):38-48. PubMed ID: 6743422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Thierfelder L; Holubarsch C; Hasenfuss G; Heiss HW; Just H
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):593-9. PubMed ID: 1711626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy.
    Holubarsch C; Hasenfuss G; Allgeier M; Heiss HW; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():257-65. PubMed ID: 2530975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling between myocardial oxygen consumption and mechanics in patients with dilative cardiomyopathy. Influence of vasodilation and positive inotropism.
    Hasenfuss G; Holubarsch C; Heiss HW; von Herrath M; Just H
    Prog Clin Biol Res; 1989; 315():613-5. PubMed ID: 2529573
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of MDL 17,043, a new cardiotonic agent, in patients with congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt C; Haegele KD; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1983; 5(6):998-1004. PubMed ID: 6196573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
    Permanetter B; Baumann G; Wirtzfeld A; Günes S; Stinshoff M; Klein G
    Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.